| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI1185AHU165181B (en) | 1971-11-08 | 1971-11-08 |
| Publication Number | Publication Date |
|---|---|
| CA978479Atrue CA978479A (en) | 1975-11-25 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA155,789AExpiredCA978479A (en) | 1971-11-08 | 1972-11-07 | Composition for the dissolution of renal calculi and process for the preparation thereof |
| Country | Link |
|---|---|
| AT (1) | AT332531B (en) |
| CA (1) | CA978479A (en) |
| CS (1) | CS217603B1 (en) |
| DD (1) | DD100631A1 (en) |
| DE (1) | DE2252665A1 (en) |
| GB (1) | GB1403900A (en) |
| HU (1) | HU165181B (en) |
| IL (1) | IL40685A (en) |
| SU (1) | SU1009467A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2826642C2 (en) | 1978-06-19 | 1987-04-23 | Dr. Madaus & Co, 5000 Köln | Oral urolithiasis agent |
| DE3046580A1 (en)* | 1980-12-11 | 1982-07-01 | Leskovar, Peter, Dr.-Ing., 8000 München | Prophylactic and curative treatment of urinary calculi - by admin. of organic acid, dye, metal oxide, etc. |
| DE3728814A1 (en)* | 1987-08-28 | 1989-03-30 | Lentia Gmbh | SOLUTION FOR USE AS A RINSING LIQUID IN THE DESTRUCTION OF NON-BODY DEPOSITS IN HUMAN AND ANIMAL TISSUES OR BODIES |
| JP2545479B2 (en)* | 1989-02-07 | 1996-10-16 | ミッション ファーマカル カンパニー，インコーポレーテッド | Pharmaceutical composition |
| CA1326040C (en)* | 1989-11-16 | 1994-01-11 | Neill B. Walsdorf | Magnesium-potassium citrate |
| DE4409949C2 (en)* | 1994-03-23 | 1996-11-21 | Madaus Ag | Use of calcium alkali citrates for the prophylaxis and treatment of degenerative diseases of the bone structure |
| DE10028167B4 (en)* | 2000-06-09 | 2004-02-19 | Storch, Rüdiger, Dr. | Use of calcium salts to counteract the formation of oxalate stones |
| WO2009143021A1 (en)* | 2008-05-22 | 2009-11-26 | Bristol-Myers Squibb Company | Method for treating and preventing kidney stones employing an sglt2 inhibitor and composition containing same |
| FR2967576B1 (en) | 2010-11-18 | 2013-07-12 | Advicenne Pharma | PHARMACEUTICAL COMPOSITION COMPRISING KREBS CYCLE PRECURSOR SALT, IN PARTICULAR CITRATE SALT, AND ITS USE AS A MEDICINAL PRODUCT |
| FR2967578B1 (en) | 2010-11-18 | 2012-12-28 | Advicenne Pharma | PHARMACEUTICAL COMPOSITION COMPRISING CITRATE AND BICARBONATE SALTS AND USE THEREOF FOR THE TREATMENT OF CYSTINURIA |
| WO2014152789A1 (en)* | 2013-03-15 | 2014-09-25 | New York University | Citrate containing beverage |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3328304A (en)* | 1964-07-31 | 1967-06-27 | Guardian Chemical Corp | Chelating agents and methods for their manufacture |
| FR2019261A1 (en)* | 1969-03-19 | 1970-07-03 | Melon Jean Marie | Treatment of oxalic lithiase with succinic - acid and its derivs |
| Publication number | Publication date |
|---|---|
| SU1009467A1 (en) | 1983-04-07 |
| HU165181B (en) | 1974-07-27 |
| GB1403900A (en) | 1975-08-28 |
| IL40685A (en) | 1976-08-31 |
| DE2252665A1 (en) | 1973-05-10 |
| ATA925372A (en) | 1976-01-15 |
| DE2252665C2 (en) | 1987-09-10 |
| DD100631A1 (en) | 1973-10-05 |
| CS217603B1 (en) | 1983-01-28 |
| IL40685A0 (en) | 1972-12-29 |
| AT332531B (en) | 1976-10-11 |
| Publication | Publication Date | Title |
|---|---|---|
| CA980353A (en) | Substituted phenylalkanol derivatives and process for the preparation thereof | |
| CA978479A (en) | Composition for the dissolution of renal calculi and process for the preparation thereof | |
| CA979437A (en) | 15-oxoprostanoic acid derivatives and process for the preparation thereof | |
| CA1003631A (en) | Antiozonant-antioxidant composition and process for preparation thereof | |
| AU4176372A (en) | New pyridylpiperazines and process for their preparation | |
| CA996026A (en) | Hormone and process for the preparation thereof | |
| CA959843A (en) | Process for the preparation of 1-phenyl-4-amino-cyclohex-2-ene-1-carboxylic-acid-esters and the salts thereof | |
| AU4615372A (en) | Fungicidal composition and process | |
| AU462564B2 (en) | Substituted isoquinolones and process forthe preparation thereof | |
| CA989874A (en) | Process for the preparation of pentafluorethyl iodide and heptafluorisopropyl iodide | |
| CA998049A (en) | Pyrazinoindole derivatives and process for the preparation thereof | |
| AU5019272A (en) | Composition and process | |
| CA1006522A (en) | N-acyl-(piperazinoalkyl)-pyrazoles and process for the preparation thereof | |
| AU481489B2 (en) | Composition for the dissolution of renal calculi and process for the preparation thereof | |
| CA966777A (en) | Delayed action antiseptic composition and the process for its preparation | |
| CA983958A (en) | Process for the preparation of imines | |
| AU4815172A (en) | Composition for the dissolution of renal calculi and process for the preparation thereof | |
| CA960213A (en) | Process for the preparation of 3-azolylpropynes and compounds thereby produced | |
| CA869971A (en) | Dissolution process and composition | |
| CA992952A (en) | Process for the preparation of bufalin and related compounds | |
| AU472732B2 (en) | 17-esters of 60-90(difluoro-21-desoxyprednisolone and process for the preparation thereof | |
| CA868365A (en) | Tetrahydroisoquinolines and process for preparation | |
| CA948156A (en) | Process for the preparation of polychlorcyclopentane and hexachlorcyclopentadiene | |
| AU460636B2 (en) | Process for the preparation of diaminodiaryl-methanes and polyaminopolyarylmethanes | |
| CA873339A (en) | Amphoteric starch and process for the preparation thereof |